Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).
Notes:
Prevalence estimates for ecstasy exceed those for amphetamine in 14 of the EU and candidate countries that participated in the 2003 ESPAD survey of 15 to 16 year old school students.
*German data is based on six regions only (Bavaria, Brandenburg, Berlin, Hesse, Mecklenburg-Western Pomerania and Thuringia). Turkey figures are based on one major city in each of 6 different regions (Adana, Ankara, Diyarbakir, Istanbul, Izmir and Samsun).
**Spain did not participate in the ESPAD survey. The data included here is based on a Spanish survey conducted November-December 2002. Drug prevalence questions may be considered comparable to the ESPAD questions but other aspects of the method mean that the Spanish data is not strictly comparable.
See also 'General notes for interpreting data' on the Explanatory notes and help page.
Sources:
Hibell et al., 2004